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RESEARCH ARTICLE
User-centred health design: reflections on D4D’s experiences and
challenges
Louise Moody*
Department of Industrial Design, Coventry University, Priory Street, Coventry CV1 5FB, UK
Abstract
There is increasing recognition of the importance of user-centred design and testing in the
healthcare technology domain. Challenges associated with user and stakeholder involvement
in designing solutions for healthcare are recognized in the literature and need to be addressed
to facilitate the development of new technology that is usable and acceptable to the end-user.
The Devices for Dignity Health Technology Cooperative (D4D) has been involved in a range of
technology development projects with an underpinning approach of addressing unmet needs
through user involvement. This paper provides practical examples of some of the challenges
that occur at different stages during a user-centred design process including ethical approval
processes; stakeholder and user recruitment and involvement; eliciting needs from users
regarding sensitive and personal issues; and interdisciplinary working. The paper will describe
some of the strategies that have been employed by D4D to overcome these challenges and
facilitate technology development.
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1. Introduction
The importance of applying design approaches in healthcare
is increasingly accepted [1–6] with growing recognition of the
need for the NHS to embed user-centred and design thinking
approaches [7,8]. Health Design is a relatively nascent
interdisciplinary research area bringing together fields such
as design, healthcare, engineering, ergonomics, physiother-
apy, occupational therapy, design, social research, etc. [9].
User-centred design (UCD) is a development approach in
which end-users influence and are involved in design; it is
both a philosophy and variety of methods [10,11].
The UCD approach typically involves identifying the
intended users of a device, then ascertaining and prioritizing
their needs and requirements, as well as the task require-
ments; developing and testing prototypes; evaluating design
alternatives; analysing and resolving usability problems; and
testing the design and its features with users in an iterative
manner [11]. UCD can involve consulting users about their
needs and involving them at specific points during the design
process; or it can involve users being involved as partners
and co-designing throughout the development process
[10,12,13].
Whilst the approach has been criticized for the cost and
time required to apply it effectively, the benefits are clear
[11,14–16]. Studies report improved functionality, quality,
usability and acceptability of resulting designs and, therefore,
a reduction in product failure [11,15,17–19]. By detecting
usability problems early in the development process and
developing only relevant functionality the costs and time
associated with re-development are reduced [14]. An easy to
use end-product increases effective usage, customer satisfac-
tion and product sales [20]. Reviews by Bevan [21] and Bias
and Mayhew [14] explore the potential benefits and provide
statistics to support cost savings as well as the potential to
increase sales. Within a healthcare context, designs that are
usable and accepted by the intended user group increase the
likelihood of appropriate product usage encouraging healthy
behaviours and outcomes [22].
There are, however, challenges to undertaking user-centred
design [17,23] and particularly so in healthcare [1,5,24,25].
Whilst some of the challenges are acknowledged in the
literature, there is a need for more discussion of these
challenges and how they can be tackled at a practical level
[26]. Therefore, this paper will build on the literature and
draw together some of the key issues that have been
experienced and addressed through D4D projects.
2. The D4D approach
The Devices for Dignity Healthcare Technology Co-operative
(D4D) brings together Industry, Academia and the NHS to
design and develop innovative technology solutions to support
people with long-term conditions [27–29]. To improve
independence and dignity, user willingness to uptake,
engage wit, and effectively use the resulting technology is*Corresponding author. Email: l.moody@coventry.ac.uk
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essential; it is argued that this is most successfully achieved
by involving the user in the development process.
The involvement of users and stakeholders as advisors,
users, testers and co-designers ensures usable, acceptable and
desirable solutions are developed that meet the needs of users
with a diverse range of capabilities [10,13,30].
Figure 1 illustrates a typical D4D UCD design process.
A project is initiated through an unmet clinical need or an
idea of a device to address an unmet need. In order to
understand and validate that need, the user, stakeholder and
expert group related to the potential device will be
determined. Through that group, the need is validated and
the requirements for the device will be established and
prioritized. This may involve research to understand the user,
tasks, experiences and context of use in detail, for example
though focus groups, observation and interviews. Goals for
the device will be established, for example in terms of
usability, improved dignity, safety and design criteria.
The design and development process will then begin; in
some cases this may be from initial ideas and concepts, in
other cases D4D will have been presented with a device that is
already at the prototype stage. User and stakeholder involve-
ment will be sought to inform and test ideas, concepts, mock
ups and prototypes iteratively through the design process; and
then to evaluate against the established goals and require-
ments. The UCD process sits within a wider D4D innovation
model which also supports the adoption and dissemination of
the resulting technology [27].
3. UCD challenges
D4D has worked on a range of different innovations within its
specialist focus areas (assistive and rehabilitation technology;
renal technologies, urinary continence management and
paediatrics). Some of the challenges that have been
experienced are discussed with the aim of facilitating future
end-user engagement in healthcare design.
3.1. Identifying the unmet need
NHS-based research can be challenging; the NHS is a large
and complex organizsation, with varying practises in different
hospitals and wards, and an array of areas where design might
be applied [26,31,32]. The principle for D4D was to create
‘technology pull’ into the NHS, targeting real user needs
rather than being driven by technology or academic areas of
interest [33].
The identification as well as the validation of unmet needs
is important to determine whether a project should be
pursued. Identifying needs is typically achieved through
patient and public involvement, working with relevant
charities and healthcare professionals. The D4D website
also facilitates the submission of unmet needs by members of
public, patients, carers, researchers, inventors, etc.
Projects are selected on the basis of an expert-led multi-
criteria review process, ensuring that there is a clear unmet
clinical need as well as the potential for a technology-based
solution to enhance dignity and independence. Further project
definition and validation is undertaken through various
different formats, for example patient focus groups, meeting
with clinicians and surveys through charities and patients’
associations. The impact on the end-user, the NHS and the
market to benefit are considered. Those selected will be
pursued through D4D pump-priming and commercial or
public funding.
3.2. Defining the user group, stakeholders and
development team
Technology development is reliant on the right project team.
As well as having NHS Trusts, University and charities as
formally recognized partners; the D4D network aims to seek
out the right clinical, academic and commercial expertise on a
project-by-project basis. Appropriate multi-disciplinary
expertise and user and stakeholder involvement throughout
the project lifetime ensures complimentary expertise is in
place to develop and deliver projects [29].
Successful design should take into account the needs of,
and potential impact upon, a wide range of users and
stakeholders [34,35]. Device users are only one group of
stakeholders and usually wider involvement is needed [36,37].
Carers and family, service providers, community and hospital-
based clinicians, manufacturers, procurement agencies, etc.,
all have an influence on the adoption of healthcare products
and services [38]. It is important, therefore, to consider which
users and stakeholders should be involved, in what way, and at
what point of the UCD development path.
3.2.1. Gaining and maintaining access
Gaining and maintaining direct access to healthcare technol-
ogy users and their carers as well as clinical and healthcare
Figure 1. A UCD development process.
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professionals can be time-consuming and challenging [17].
The UCD process is iterative and can be complex, lengthy,
constrained and expensive, so it is perhaps not surprising that,
during product development, user and stakeholder consult-
ation can be neglected [39]. There are often transport and
logistical issues to be addressed and funds need to be
allocated to this element of activity. Caregiver and healthcare
professional priorities are the delivery of patient care and
informing a research or design project may be difficult for
them to allocate time and resources to.
3.2.2. Stakeholder and user groups and networks
If regular involvement of users and stakeholders is sought, the
time, logistics and financial implications have to be planned
carefully at the start of the project to ensure genuine
involvement is feasible and contributes to the technology
development needs. D4D projects tend to involve a stake-
holder group from the outset to represent different perspec-
tives, feedback throughout the development and potentially
influence final acceptance and use of a device [39].
This involvement is enabled through patient groups,
charities and Partner NHS Trusts. As project ideas are often
initiated by clinicians, this can offer a motivated source of
expertise and gatekeeper access to potential end-users. Being
based within Sheffield Teaching Hospitals NHS Foundation
Trust and with five partner NHS Trusts involved, there is local
access to the clinical setting and patient groups which relieves
some of the logistical, transport and financial challenges.
To further facilitate user and stakeholder involvement, D4D
has established a National Expert Network to engage users,
carers and clinicians. The network is comprised of established
user groups and a network of businesses, charities, academics
and NHS Trusts that enable rapid identification and involve-
ment of users and stakeholders. The network facilitates the
involvement of hospital and community settings and recog-
nized relevant experts. This has helped recruitment to studies,
guided the development process, as well as facilitating sharing
of the resulting technology with the wider community.
3.2.3. Purchasing, procurement and health economics
Whilst the NHS advocates patient choice [40], the appliances,
products and devices available are limited to pre-selected
options and can vary widely. Those available are influenced
by bodies responsible for purchasing for the NHS and
organizations with a role in influencing the adoption of new
products; cost is clearly a factor [41–43]. Whilst working
directly with manufacturers increases the likelihood of a
product getting to market, the uptake of the product within the
marketplace is also essential [44].
For adoption, a device should be addressing a real NHS
challenge or unmet need that can be articulated in terms of
quality-of-life. Health technology is assessed and compared in
terms of QALYs (quality-adjusted life years). This provides a
common measure for assessing health gain and results and
takes into account both the quantity and quality-of-life
generated by the healthcare intervention. When combined
with the cost associated with an intervention, it is used to assess
relative worth from an economic perspective [45]. The cost per
QALY will influence an NHS purchasing decision.
D4D has included stakeholders from the NHS Supply
Chain, NHS Purchasing Consortium and NHS Prescription
Services, NHS Technology Adoption Centre, Life Sciences
Innovation and NHS National Innovation Centre to give
feedback on how a product would be assessed for its value to
the NHS and in identifying and addressing potential barriers
to the uptake of a product [39]. The constraint of item cost on
healthcare design is significant, so the importance of
involving purchasing and procurement as stakeholders in the
development process in defining requirements is becoming
increasingly clear. Equally the involvement of healthcare
economics expertise is important to ensure cost-
effective development, evaluation and adoption of the D4D
portfolio [46].
3.2.4. Ethical approval
Many D4D projects involve new materials, techniques or
testing ideas with users for the first time and are, therefore,
subject to ethical review to protect the interest of patients and
the public involved in the research. Where the project involves
NHS staff, patients and premises and is defined as research,
ethical approval will be sought through the National Research
Ethics Service (NRES) and granted by the Research Ethics
Committees (RECs) [47]. Local NHS R&D permission is also
sought with the collaborating NHS Trusts who review the
feasibility and logistics of undertaking the research locally,
undertake contract and budget negotiations, ensure compli-
ance with legislation and issue Letters of Access or Honorary
Research Contracts for non-NHS research, e.g. academics.
Whilst the ethical review system has evolved, these
processes remain complex and time-consuming, particularly
when there are multiple centres involved which can result in
local variations in protocol [48–51]. There is a significant
level of administration and dependencies on the R&D
departments, occupational health and HR departments at the
Trusts for timely delivery [49].
The nature of user-centred development means it does not
readily fit into the mould of a clinical trial. It can be
challenging to be specific about the prototype to be tested, the
way in which it will be used, participant sampling and
timeframes, prior to user needs research being carried out.
Multiple applications may, therefore, need to be made during
a project lifespan to cover user research through to evaluation.
From a project management perspective, D4D plan early and
where possible develop protocols for funding application that
will dovetail with NRES processes. The application process is
initiated as soon as funding is awarded to ensure approval
times do not hamper timely completion of the project.
Some D4D projects are not research related and can be
classified as audit, service evaluation or system/equipment
testing [52]. These activities involve minimal additional risk,
burden or intrusion for participants and are regulated outside
of NRES (Health Research Authority). The rationale for
consideration of technology development projects outside of
this sphere is where the aim is not new generalizable
knowledge. User requirements driven work for example Q1,
involves assessing whether existing solutions are adequate
(service evaluation); whereas testing new solutions (i.e.
interventions not already in use) would be deemed research
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and would require REC review. Advice is sought from the
local R&D departments involved to confirm the appropriate
classification of projects.
3.3. Elicit and prioritize needs, requirements
and goals
D4D has focused on developing devices in areas of unmet
need in specialist areas [27]. Within these areas, users, their
needs and goals can be diverse, based on a variety of factors
such as the nature of the medical condition, age, gender,
personal wants and needs, physical and cognitive capabilities,
lifestyle choices and environment.
3.3.1. Discussing sensitive issues
Eliciting needs regarding sensitive and personal issues (for
example urinary continence) can be challenging, with
users reportedly being unwilling to discuss their experiences
[53–55]. The D4D network and relationships with clinical
specialists and charities provides access and builds relation-
ships with users with conditions that they may usually be
reluctant to discuss. Our experience suggests that, once
recruited, participants are keen to engage and remain involved
in projects. They have the opportunity to talk and explain
problems and share their stories in a non-threatening envir-
onment. Often in the case of urinary continence, it is a
condition users might ‘keep secret’ and problems they
assumed were their own, they are reassured to find are
‘normal’ within a similar population. This experience can be
empowering [56]. By focusing on unmet clinical needs, D4D
has benefitted from participation from users motivated to
improve their quality-of-life and the products they have to use.
3.3.2. Supporting complex needs
The users that D4D encourage design involvement from may
have complex needs and impairments affecting their mobility,
communication or ability to give informed consent to
participate [56–59]. They may be reliant on carers to facilitate
their transportation, access and participation. The organiza-
tion of user involvement sessions, therefore, takes into
account participant’s requirements and minimizes the chal-
lenges as far as possible.
Research methods and facilitator style need to be flexible
to cope with user preferences and to ensure an empathic
approach [59,60]. Focus groups as well as interviews (face to
face and telephone) have been used, acknowledging the
participants needs and preferences and specific tools and
resources have been developed to aid user involvement and
facilitate discussion [58,59]. Carers have a role in supporting
user involvement, but are also secondary users that have a
voice to add [41,59]. The use of supplementary materials and
carer support may lead and influence the data collected, but it
is important to allow inclusion of users with diverse needs and
enable reflection on the carer perspective and requirements.
3.3.3. Prioritizing requirements
From the researcher and designer perspective, users sharing
in-depth personal experiences is extremely valuable [61].
Processing these views and a large volume of qualitative data
can be difficult. A passionate view of significant issues for
one user may not represent the views of many. Once the
designer/researcher has personally connected with the user,
the desire to solve their problems can be strong. Equally, there
may be a very diverse set of needs emerging, so eliciting and
prioritizing needs for a single device can be challenging. To
ensure valid issues are being prioritized and addressed,
consultation is undertaken with clinical specialists, relevant
charities and patient fora to verify findings are of significance
to a larger group.
Along with a design specification, a list of prioritized user
requirements helps to specify up-front in a design project
exactly what the device needs to achieve for the specified
group of users [17]. Where there are multiple stakeholders
and users with variable needs, prioritization may not be
straightforward and may be time-consuming in terms of data
analysis [38,62]. There is rarely a ‘one size fits all’ solution.
For example, a project looking to improve the usability of leg-
worn urinary drainage systems highlighted the need for a
range of solutions to cater for a wide range of different
physical and cognitive capabilities and lifestyles [41,61].
There is a need for methods to minimize bias and prioritize
requirements so that a design caters for most users or the most
severe problems. Consideration is also needed of materials
and manufacturing costs, as well as the complexity of device
regulation. There are methods and processes that can be used
to help inform these choices and prioritize requirements, for
example, Quality Function Deployment [63], Analytical
Hierarchy Process [64], Conjoint Analysis [65] and cost-
value approaches [66]. Often in design, the decision-making
process is less formal and relies on consensus and the
experience and skills of a multidisciplinary team to prioritize.
The D4D stakeholder and clinical expert involvement is
essential to assess, prioritize and balance requirements.
3.4. Design and prototype
In UCD, and demonstrated through D4D projects, user
involvement in the design and prototyping stages can be on
a continuum from informative through to participative [67].
Druin [68] defines four levels of user involvement: (1) User:
tests a final concept to see how it works; (2) Tester: tests
prototypes once initial design work is complete; (3)
Informant: plays a part in the design process at various
stages determined by the designer; (4) Design partner:
throughout the whole design process.
3.4.1. Examples of user involvement in design
Ideally, involvement starts as early as possible to ensure that
the project is addressing an unmet need and involvement is
influential [69]. Close, and early user involvement ensures
accurate requirements and a better match between the
decisions of the design team and the needs and task of the
user. Concepts, mock-ups and prototypes are used to develop
and test out ideas before the design process has progressed too
far and it becomes more costly to make changes. However, in
some projects D4D may become involved relatively late in the
development of a device, so then the end-user may act as a
user or tester of a more developed concept. The level of user
involvement and extent to which users and stakeholder are
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co-designing, therefore, varies, as illustrated in the following
examples.
 Example 1: A D4D workshop was run to develop project
ideas in the area of assistive technology. One of the
projects to arise was looking at the design of the leg-worn
urine drainage bag. This led to an NIHR i4i grant to
further explore user needs and potential design improve-
ments. The data from this study provided many insights
into design and functional limitations of currently
available leg bags; the challenge was deciding which of
the many issues to address. Here, requirements and
design decisions were prioritized based on their impact
on user dignity, in this case limiting the risk of accidental
leakage and the discretion of the bag under clothing. End-
users came together to test and feedback on the usability
of the prototypes developed by the design team before the
designs were finalized [41,61].
 Example 2: This was aimed to develop an innovative
shower chair to meet the needs of the active, independent,
self-purchasing wheelchair user, allowing them freedom
to travel and participate in sports. D4D consulted multi-
disciplinary specialist clinicians at a Spinal Injuries Unit
and groups of spinal-injured participants. Extensive
feedback was collected on existing designs of mobile
shower chairs and preliminary designs for the new
prototype in terms of effectiveness, ergonomics, aes-
thetics, etc. It was interesting to explore the emerging
requirements from the end-users and the clinicians in this
project. The clinicians were more focused on minimizing
risk to the user; whilst the users themselves were more
focused on their lifestyle and cost.
 Example 3: NIHR i4i grant funding was awarded to
further develop a prototype urinary catheter with a novel
deployment and retention mechanism. The inter-discip-
linary development team involved clinical representation,
urinary continence research specialists, scientists, engin-
eers, a manufacturer of continence products and a
usability specialist. The development process was itera-
tive with three cycles of usability testing and re-design
with clinical staff co-designing features of the device
[39]. Usability testing was undertaken on a Limbs &
Things Catheterization Trainer to enable repeated and
relatively realistic deployment of early prototypes with-
out the ethical issues associated with testing on a patient.
In this project it was a challenge of balancing the need to
have a tangible product to discuss, without having
invested too much on development to that stage. There
was a need to explain the limitations of the prototype
quality and the cost implications of significant design
changes. Over time a clear understanding of clinical and
manufacturing priorities developed and supported the co-
design process.
 Example 4: In collaboration with Frazer-Nash
Consultancy, D4D aimed to design a paediatric wheel-
chair that would improve independence, whilst incorpor-
ating complex equipment needs such as ventilators and
oxygen cylinders. A survey was undertaken to elicit
needs and resulted in a surprisingly large and passionate
response over a 2-week period (114 wheelchair users,
190 carers and 164 professionals) [59] and wide ranging
requirements. The analysis led to 10 key themes, which
were further prioritized and developed through a design
workshop. Children and their carers took part in the co-
design workshop, hosted by the charity Whizz-Kidz
[33,59]. The participants gave feedback on some initial
design concepts and reviewed existing technologies.
They were then asked to build up a design for a new
device using constituent parts from the solutions pre-
sented. One key challenge addressed through the work-
shop design was facilitating effective engagement and
co-design from diverse participants including children
[59]. The design output was reviewed by a stakeholder
group, who finalized the design to take forward.
3.4.2. Benefits of co-design
The process of user and stakeholder involvement in the design
process is rewarding to both the user and the research team. It
builds capacity, skills and is based on the premise of equal
value of expertise, whether that be design, health, academic or
personal experience. We have found useful design ideas
coming from different life experiences, for example a user
recommending a plumbing component with relevance to the
design of an incontinence product. Co-design activities build
empathy in the design professionals (designers, engineers,
material scientists, researchers, etc.) involved as they see the
perspective of the user more clearly and understand their
requirements; whilst it provides the user insight into design
processes, perspectives and methods.
3.4.3. Challenges of co-design
Whilst user and stakeholder involvement in co-design
activities is beneficial, there are a number of reported
challenges [17,69,70]. Co-design participants need to be
willing to share their experiences and ideas with new people;
help others have empathy with their condition; and have the
confidence to put forward their ideas. They may appear
resistant to change, be afraid to critique honestly, find it
difficult to convey their ideas, request significant changes
with little awareness of design constraints or fail to reach a
consensus [17,71]. Co-design workshops can be challenging
in terms of ensuring involvement through different activities;
balancing personality and confidence issues and differences in
work pace [60]. Equally, designers can be criticized for
adding unnecessary complexity, focusing on styling and use
of subject-specific language when working directly with end-
users [17,71].
In D4D projects these challenges have been addressed
through careful use of language, explanation of the process
and the development of tailored design tools. The use of a
facilitator has been found to be advantageous in resolving
conflicting views and when users may lack confidence or
need support contributing. The nature of the co-design
exercise and format is also important for adapting to
individual needs and styles; for some, smaller group or 1:1
sessions might be more appropriate.
Rapid prototyping and storyboarding tools are useful for
demonstrating designs to non-designers. In our experience,
users can find it hard to visualize a final product from a sketch
or early prototype. Mock-ups and prototypes are useful to
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demonstrate the form of the device and to gain user feedback,
but users can sometimes be distracted by the appearance and
feel, detracting from the focus on functionality and usability.
Rapid prototyping has been used, for example, to produce
valves for leg bags and non-invasive ventilation masks. As it
can be challenging to get the feel and final functionality right,
it is important to manage user expectations.
Going forward there is a need to further consider tools for
presenting ideas, mock-ups and prototypes to support visual-
ization so that users are not frustrated or disheartened by
limited functionality and basic prototypes. The growth of 3D
printing offers significant potential as it will become quicker,
easier and cheaper to provide realistic prototypes with greater
potential for customization as the technology evolves [72,73].
Briefings on the design process to educate users in the process
and to set realistic expectations on what can be achieved
within the context of design constraints and competing
demands for resources is recommended.
3.4.4. Interdisciplinary team working in design
The involvement of non-designers (SMEs, subject matter
experts, developers, scientists, etc.) in design can lead to
challenges in terms of collaboration and shared understanding
and communication [70]. Members of D4D come from varied
backgrounds—health and care providers; academic research-
ers; charities; health commissioners; health technology
industry. The range of disciplines will vary on a project-by-
project basis. The differences in working practises, methods,
language and communication, ways of thinking and the desire
to problem-solve and innovate between disciplines have to be
negotiated [34].
However, as a result of multi-disciplinary collaboration
D4D projects are very closely informed by appropriate
expertise. The involvement of a range of disciplines brings
together novelty, freedom and creative expertise with tech-
nology and condition-specific knowledge and experience.
Effective facilitation and sharing of working methods and
approaches is important to ensuring that involvement is
effective, supports ideas generation and balances conflicting
demands from the specialisms involved.
3.5. Testing and evaluation
A user-centred approach is characterized by iterative testing
and not just final evaluation [16] to ensure usability and cost
and efficiency benefits can be achieved by early identification
of issues in the development process [17,69]. Clinical trials
are used to study the impact of a device on clinical validity
and effectiveness [74]. User-centred methods such as heuristic
evaluation and usability testing are better suited for exploring
barriers to usability, acceptability and willingness to use the
device, which will in turn determine healthy behaviours [11].
A range of testing approaches is, therefore, valuable and it is
important to select the right level of testing for the questions
being asked, the user population and typical usage of the
device [75]. Qualitative as well as quantitative approaches are
important to gain an in-depth understanding of device usage.
In a healthcare environment, ethical approval, funding
requirements and impact/research assessment can lead
towards controlled trials for generating credible evidence to
establish new knowledge or clinical impact [75]. In contrast,
in design, iterative testing is employed to explore how to
develop and improve a design and to understand usability,
user and market acceptance. This variation in approach can be
a challenge in developing project plans and evaluation
strategies for interdisciplinary projects [34]. A final product
evaluation in the form a clinical trial will often require
additional ethical approval processes and recruitment and
may be subject to additional funding beyond that secured for
device development purposes. In contrast, iterative testing is
more likely to be embedded within a project plan, funding and
ethical approval for the development of a device.
The D4D approach has focused on collecting different
forms of evidence to support the further development or
production of a device, as well as looking to demonstrate
clinical benefit. The following provide examples of various
testing methods that have been employed:
(1) User feedback: To gain iterative feedback on designs
as they evolve, as well as a final prototype or device
[33,76].
(2) Expert assessment: Drawing on networks of healthcare
experts, scientists and academics to assess the solution
against the clinical context [39,76].
(3) Usability testing with end users: To assess ease of use
and acceptability [39,76].
(4) Heuristic evaluation: To assess and improve usability
[11,39].
(5) Health economics and market analysis [76].
(6) Clinical trials.
Where medical devices are developed, they are subject to
regulatory approval [74,77]. It may be necessary to carry out a
clinical trial in order to obtain CE marking for a medical
device and demonstrate that the device is compliant. This
topic is discussed more fully in another paper within this
special issue. The approach taken to testing, therefore,
depends on the stage of development and the context in
which the device will be used.
Table 1. Identified challenges of UCD of healthcare devices.
A summary of UCD challenges
 Gaining and maintaining access to users, carers and healthcare
professionals
 Reaching and engaging relevant stakeholders
 Maintaining involvement
 The time, logistics and resources required for involvement
 Managing the ethical review and approval process for multi-stage
design projects
 Managing the regulatory frameworks for medical devices
 Involving users at the early stages of the design process
 Adapting methods to meet individual participation needs
 Discussing and deriving user requirements on personal health issues
 The time, logistics and resource requirements for managing the
resulting data
 Rationalizing and prioritizing competing user and stakeholder
requirements
 Minimizing bias in the prioritization of requirements
 Cost as a significant design constraint
 Differences in knowledge, working practises, language and ways of
thinking, between disciplines
 Communicating design thinking and ideas effectively to users and
stakeholders
 Devising testing and evaluation strategies to match ethical, funding
and discipline expectations
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4. Conclusions
UCD in the healthcare context involves taking users on a
journey, involving them in the research and development
process, whilst offering the potential that the resulting device
will improve their dignity, independence and health. The final
product will always be a balance of competing demands
placed by a variety of stakeholders: the users, the healthcare
professionals, the buyers and purchasers, the regulators; and
constraints in terms of the cost of materials and manufacture.
However, it is important that, where possible, effective
solutions are delivered back to the user.
Involving a diverse range of users and stakeholders, is not
straightforward; but it is argued that working closely together
ensures that development is driven by real need and the final
product is one that is acceptable and usable. In order for the
UCD approach to be applied effectively, project planning
should take into account some of the challenges that face
UCD as it is applied in healthcare. Based on the experience of
embedding it as part of the D4D development process, some
of the key challenges are summarized in table 1.
The design of effective devices, products, systems and
services for healthcare requires expertise from diverse fields
and user and stakeholder involvement. As the benefits of
UCD are becoming widely accepted, research should focus on
strategies to reduce the challenges associated with designing
for health and finding practical working approaches to
facilitating user involvement. The design and usability of
technology should not be a barrier to healthy behaviours and
to the uptake and continued use of clinically-effective
products.
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